T-cad (T-cadherin), a glycosylphosphatidylinositol-anchored cadherin superfamily member, is expressed widely in the brain and cardiovascular system, and absent, decreased, or even increased, in cancers. Mechanisms controlling T-cad expression are poorly understood. The present study investigated transcriptional regulation of T-cad in ECs (endothelial cells). Conditions of oxidative stress (serum-deprivation or presence of H 2 O 2 ) elevate T-cad mRNA and protein levels in ECs. Reporter gene analysis, using serially deleted T-cad promoter stretches ranging from − 99 to − 2304 bp, located the minimal promoter region of T-cad within − 285 bp from the translation start site. Reporter activity in ECs transfected with the − 285 bp construct increased under conditions of oxidative stress, and this was normalized by antioxidant N-acetylcysteine. An electrophoreticmobility-shift assay revealed a specific nucleoprotein complex unique to − 156 to − 203 bp, which increased when nuclear extracts from oxidatively stressed ECs were used, suggesting the presence of redox-sensitive binding element(s). MS analysis of the nucleoprotein complex unique to − 156 to − 203 bp after streptavidin-agarose pull-down detected the presence of the redox-active protein thioredoxin. The presence of thioredoxin-1 in a nuclear extract from oxidatively stressed ECs was demonstrated after immunoprecipitation and immunoblotting. Transfection of ECs with thioredoxin-1 small interfering RNA abrogated oxidative-stress-induced up-regulation of T-cad transcripts and protein. We conclude that thioredoxin-1 is an important determinant of redox-sensitive transcriptional up-regulation of T-cad in ECs.
INTRODUCTION
T-cad (T-cadherin, also called cadherin-13 and H-cadherin) is an unusual GPI (glycosylphosphatidylinositol)-anchored member of the cadherin superfamily. Described functions for T-cad are diverse and vary with cell type. In the embryonic system, T-cad functions as a negative guidance regulating motor-axon outgrowth [1] . T-cad inhibits invasion and growth in some cancers (e.g. breast, lung and colon; reviewed in [2] ), but promotes epithelialto-mesenchymal transition, invasion and/or proliferation in others (e.g. metastatic liver and lung cancers) [3, 4] . In the vasculature, T-cad is up-regulated during atherosclerosis [5] and in tumourpenetrating blood vessels [6] , has growth-promoting [7, 8] and survival functions in vascular cells [9] [10] [11] and stimulates angiogenesis [12, 13] . T-cad has also been attributed receptor functions for low-density lipoproteins [14] and high-molecularmass adiponectin [15] .
Transcriptional regulation of T-cad is poorly understood. The T-cad gene has been localized on chromosome 16q24, along with the genes for a few other cadherins [16] . Frequent epigenetic modification of T-cad promoter by aberrant methylation, resulting in allelic loss and diminished expression of T-cad, has been reported for a variety of cancers, including breast [17] , lung [18] , colorectal [19] , cervical [20] , nasopharyngeal [21] , digestive tract [22] , skin [23] and pancreatic [24] , and also for chronic myeloid leukaemia [25] and malignant B-cell lymphomas [26] . In PC12 cells, T-cad has been demonstrated to be a target gene for Dnmt3b (DNA methytransferase 3B), but Dnmt3b-dependent suppression of T-cad expression occurs via methylation-independent mechanisms [27] . Other studies have investigated external factors regulating expression of T-cad. In silico analysis of 5 upstream promoter region of T-cad gene revealed potential binding sites for GR (glucocorticoid receptor), progesterone receptor and ER (oestradiol receptor) and, in osteosarcoma cells, glucocorticoids and sex steroids were found to variously influence T-cad transcription and/or protein expression [28] . AHR (aryl-hydrocarbon response) elements have also been identified [28, 29] and polycyclic aromatic hydrocarbon Ahr (arylhydrocarbon receptor) agonists were found to suppress T-cad transcript and protein expression in vascular smooth-muscle cells [29] . In a study on prostate development, potential androgenresponsive elements in the 5 upstream promoter region were suggested as a possible mechanism mediating suppression of T-cad gene expression in response to androgen [30] . T-cad protein expression is up-regulated by fibroblast growth factor [31] and, under conditions of oxidative stress [10] , in ECs (endothelial cells). Mechanisms regulating induction of T-cad gene expression in EC have not been investigated.
In the present study we have characterized the minimal promoter region of T-cad in EC by reporter-gene analysis, identified the putative presence of redox-sensitive regulatory elements within the − 156 to − 203bps stretch by gel-shift assay Abbreviations used: AHR, aryl-hydrocarbon response; Ahr, aryl-hydrocarbon receptor; AP-1, activator protein 1; ASK1, apoptosis signal-regulating kinase 1; C/EBP, CCAAT/enhancer binding protein; DMEM, Dulbecco's modified Eagle's medium; Dnmt3b, DNA methytransferase 3B; DTT, dithiothreitol; EC, endothelial cell; EMSA, electrophoretic-mobility-shift assay; ER, oestradiol receptor; Ets1, V-ets erythroblastosis virus E26 oncogene homologue 1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GATA-1, GATA-binding protein 1; GPI, glycosylphosphatidylinositol; GR, glucocorticoid receptor; HIF-1α, hypoxia-inducible factor 1α; HMEC-1 line, human microvascular EC line; HUVEC, human umbilical-vein endothelial cell; NAC, N-acetylcysteine; NF-κB, nuclear factor-κB; oligo, oligonucleotide; ROS, reactive oxygen species; RT-PCR, reverse transcriptase-PCR; siRNA, small interefering RNA; T-cad, T-cadherin; Trx, thioredoxin. 1 To whom correspondence should be addressed (email Therese-J.Resink@unibas.ch).
and demonstrated a requirement for Trx-1 (thioredoxin-1) in oxidative-stress-induced T-cad expression in ECs.
MATERIALS AND METHODS

Cell lines and cell culture
HUVECs (human umbilical-vein endothelial cells) were cultured on 0.1 % (w/v) gelatin-precoated tissue-culture plates in EC growth medium containing low (2 %, v/v) fetal-calf serum and EC growth supplement (PromoCell GmbH, Heidelberg, Germany) and penicillin/streptomycin (100 units/ml). The HMEC-1 (human microvascular EC) line was cultured in the same medium supplemented with 10 % (v/v) fetal-calf serum. 
In silico analysis of T-cad promoter
T-cad promoter sequence from human chromosome16 (16q24) was downloaded from the NCBI (National Center for Biotechnology Information) database. Upstream of the start site (− 1 to − 2304 bps) was analysed using online software to identify putative binding elements for transcription factors based on GEN-OMATIX (www.genomatix.de), TRANSFAC (www.cbrc.jp) and TESS (www.cibl.uppen.edu) databases.
Preparation of constructs
The T-cad promoter sequence from − 1 to − 2304 was cloned into pGL3 basic plasmid (Promega AG, Dübendorf, Switzerland) in between the BglII and MluI restriction-enzyme sites. Various size deletions of promoter were generated by PCR with different 5 primers and a fixed 3 primer, using genomic DNA of HMEC-1 as template. The sequence of single reverse primer was 5 -TTT GTC CGA CTA GAA GCG CCC-3 (− 1 to − 21) and various forward primers were, 5 -GGC AGA GCC TCT CCT CAA-3 (− 81 to − 99), 5 -CCT GGT CAT CAG CCT CTA CC3 (− 165 to − 183), 5 -CAA ATG GGA TGC CAC CTC-3 (− 267 to − 285), 5 -CGC CAG TCC CCC GTG CAA TTC-3 (− 352 to − 373), 5 -GCC CCT CCC TGC CTT CTG CTG-3 (− 1149 to − 1170), 5 -TGT GGG AAA CGT GAG GCT AGA TC-3 (− 1561 to − 1584), 5 -GCC AGC AGA ACA GCC CAG GAA AA-3 (− 2281 to − 2304). All primers were purchased from Microsynth (Balgach, Switzerland).
Transient transfection and luciferase assay
HMEC-1 cells were transfected with the various constructs using Lipofectamine TM 2000 (Invitrogen/Molecular Probes via LuBioScience GmbH, Lucerne, Switzerland) according to the manufacturer's protocol. A total of 10 5 cells were transfected with 1400 ng of either empty pGL3 plasmid or pGL3 with promoter inserts and with 100 ng of pRLTK plasmid expressing Renilla (sea pansy) luciferase to control for transfection efficiency. Firefly (Photinus pyralis) and Renilla luciferase activity were measured 48 h after transfection using a dual luciferase assay system (Promega). Firefly luminescence readings were normalized to the Renilla values.
Preparation of nuclear extract
Nuclear extract was prepared by a modified protocol formulated by Dignam et al. [32] . Subconfluent HMEC-1 cells were briefly washed with PBS and cells were collected by trypsinization. Cells were washed with PBS, followed by incubation with Buffer A [25 mM Hepes, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT (dithiothreitol), 0.1 mM EDTA, 0.1 mM EGTA, 0.1 mM Na 3 VO 4 and protease-inhibitor cocktail (Roche Diagnostics GmbH, Manheim, Germany)] for 30 min on ice. Nonidet P40 was added to cell suspensions (final concn. 0.1 %), samples were vortexed-mixed for 10 s, then centrifuged at 17 000 g for 1 min at 4
• C. Nuclear pellets were suspended in cold Buffer C (20 mM Hepes, pH 7.9, 1.5 mM MgCl 2 , 420 mM NaCl, 0.2 mM EDTA, 25 % (v/v) glycerol, 0.1 mM Na 3 VO 4 and protease-inhibitor cocktail). Suspensions were subjected to vigorous shaking in a rotary shaker for 1 h at 4
• C and then centrifuged at 17 000 g for 10 min. Supernatants were collected, divided into portions and stored at − 70
• C.
EMSA (electrophoretic-mobility-shift assay)
Reactions were performed with following oligos (oligonucleotides):
Oligo − 1 to − 52:
-GTGCAGCCGCGTGCATGAATGAAAACGCCGCCGG-GCGCTTCTAGTCGGACAAAATG 3
Oligo − 34 to − 83: Oligo − 224 to − 284:
Oligos (Microsynth) were radiolabelled with [α-32 P]dCTP using standard techniques. Binding reactions were performed in a 15 μl volume reaction mixture containing 1 × binding buffer (25 mM Hepes, pH 7.9, 50 mM KCl, 1 mM DTT, 1 mM EDTA and 10 % glycerol), 1 μg of salmon sperm DNA, 1 μg poly(dI · dC), 1 ng of radiolabelled probe and 15 μg of nuclear extract for 30 min at 22
• C. For competition assays, nonradioactively labelled oligos or non-specific DNA (100-fold the amount of labelled, unless otherwise specified) were added 15 min prior to the labelled oligos. Samples were loaded on to nondenaturing 4 % (w/v) polyacrylamide gels. Gels were dried on to Whatmann paper and visualized by phosphorimaging. 
Real-time RT-PCR (reverse transcriptase-PCR)
The procedures and conditions for real-time RT-PCR were as described previously [12] . The primer pair specific to T-cad cDNA was:
Forward: 5 -AGA GAT GTT GGC AAG GTA GTC GA-3 Reverse: 5 -GAA CTT GGA CCT TTC TGG CCT-3
Primers were designed using the Primer Express software package (Applied Biosystems, Foster City, CA, U.S.A.) and obtained from Microsynth. Gene expression was normalized with respect to the endogenous housekeeping control gene GAPDH (glyceraldehyde-3-phosphate dehydrogenase).
Biotin-streptavidin pull-down and MS analysis
Oligo − 156 to − 203 (5 -GGAAGGAATCCGTCTTGTAAAG-CCATTGGTCCTGGTCATCAGCCTCTACCCAATGC) and its complementary oligo were biotinylated at 5 and 3 respectively. Streptavidin-agarose beads (Sigma Aldrich) were pre-adsorbed with 500 μg of BSA, 50 μg of poly(dI · dC) and 50 μg of salmon sperm DNA for 1 h at room temperature, washed three times with binding buffer as described above and resuspended in 300 μl of binding buffer. A 1 μg portion of annealed biotinylated oligo was incubated with 500 μg of nuclear extract prepared from serum-deprived HMEC-1 for 30 min at room temperature in binding buffer as described above. For competition, nonbiotinylated oligos were incubated with nuclear extract for 15 min before addition of biotinylated oligos. After binding reactions had taken place, 50 μl of pre-adsorbed streptavidin-agarose beads was added to the reaction mixture and incubation continued at 4
• C for 4 h. Protein-DNA-streptavidin-agarose pull-down complexes were processed for MS micro-sequencing by Dr Paul Jeno (Biocenter, University of Basel, Basel, Switzerland).
Presence of Trx in nuclear extracts and specific nucleoprotein complex
Nuclear extract from serum-deprived HMEC-1 was immunoprecipitated with anti-Trx-1 antibodies or non-immune IgG and immunocomplexes pulled down with Protein G-Sepharose using previously described protocols [11] . Streptavidin-agarose pull-down was performed following incubation of nuclear extracts from serum-deprived HMEC-1 with biotinylated oligo − 156 to − 203 as detailed above. Protein G-Sepharose-bound immunocomplexes and streptavidin-agarose-bound nucleoprotein complexes were resolved by SDS/12 %-(w/v)-PAGE under reducing conditions and analysed for the presence of Trx-1 by Western blotting.
siRNA (small interfering RNA) transfection
Trx-1 silencing in HUVEC and HMEC-1 was performed using a previously validated siRNA oligo 5 -AUGACUGUCAGG AUGUUGCtt [33] (lower-case letters denote dNTPs). RNA oligo 5 -CUCUGUUCGUCCAUGCACGga was used as negative control [11] . siRNA oligonucleotides were purchased from Microsynth and transfection was performed using Si-PORT Lipid [Ambion (Europe) Ltd, Huntingdon, Cambs., U.K.) according to the manufacturer's recommendations. Silencing of Trx-1 was monitored by immunoblotting at 48 and 72 h after transfection.
Western-blot analysis
The method of immunoblotting was described previously [10] . Cell lysis buffer was PBS containing 1 % (w/v) SDS and protease-inhibitor cocktail (Sigma). Protein concentrations were determined using the Lowry method, and SDS/PAGE was performed under reducing conditions. Protein loading equivalence was routinely controlled after electrotransfer to nitrocellulose membranes by staining with Ponceau S and by immunoblotting for Gαs subunit (42 kDa), β-actin (43 kDa) or GAPDH (37 kDa). The following primary polyclonal antibodies were used: antibody against the first extracellular domain of human recombinant T-cad [5] , anti-Trx-1 and GAPDH (Abcam, Cambridge, U.K.), anti-(G-protein Gαs) (Calbiochem, Merck AG, Darmstadt, Germany) and anti-β-actin (Santa Cruz Biotechnology). Secondary antirabbit antibodies coupled to horseradish peroxidase were from Southern Biotechnologies (BioReba AG, Reinach, Switzerland). The ECL ® (enhanced chemiluminescence) system (Amersham, Rockford, IL, U.S.A.) or SuperSignal West Dura (Pierce) was used for detection of immunoreactive proteins. Scanned images of immunoblots were analysed using AIDA Image software. The Figures show representative images.
To quantify T-cad protein levels, precursor (130 kDa) and mature (105 kDa) protein bands were collectively analysed. Interexperimental variation in the relative intensities of the two bands in vascular cells has been previously observed [7, 10] and was again apparent in the present study. Differential processing of T-cad proteins has not yet been studied in any cell type. However, we suppose that inherent differences between primary HUVEC isolates or between HMEC-1 stock aliquots (e.g. variable proliferation potential), or even small differences in tissue-culture conditions (e.g. variable serum lot), may partially contribute to inter-experimental variability.
Cell-viability assay
HMEC-1 cells were plated on to 96-well plates at a density of 3 × 10 4 cells/cm 2 , cultured in normal growth medium for 18 h, and, after refreshing the medium, cells were incubated for 2 h in the absence (control) or presence of different concentrations (30 μM-1 mM) of H 2 O 2 . To achieve maximum lethality, cells in a parallel plate were treated with 1 mM H 2 O 2 until cell detachment was complete (6-8 h). Fluorescence-based SYTOX TM Green inclusion assay of cell death (Invitrogen/Molecular Probes, from LuBioScience GmbH, Lucerne, Switzerland) was performed according to the manufacturer's recommendations using a fluorescence ELISA reader. The fluorescence reading under the condition of maximal lethality was arbitrarily taken as a 100 % loss of viability.
RESULTS
Minimal promoter region of T-cad is localized within − 285 bp
As a first step toward functional characterization of the T-cad promoter, we performed reporter-gene analysis with seven serially deleted fragments of different lengths within − 2304 bp from the translation start site cloned into pGL3 vector. The first series of reporter assays were conducted under normal serum-containing culture conditions ( Figure 1A ). The shortest fragment (− 99 bp) showed insignificant levels of reporter activity, ruling out the presence of any functional regulatory elements within − 99 bp. Transfection with the − 173 bp fragment resulted in a ≈ 2-fold increase in reporter activity compared with the negative control. Maximum reporter activity, which was ≈ 4-fold above negative
Figure 1 Reporter-gene analysis for the T-cad promoter
HMEC-1 cells were co-transfected with 1400 ng of various deletion fragments cloned in pGL3 and 100 ng of pRLTK (internal control). Luciferase activity was measured in cells cultured under normal serum-containing culture conditions (A) and following 3 h of serum-deprivation (B). Results show luciferase activity relative to a negative control (empty pGL3 + pRLTK) and represent means + − S.D. for at least four independent experiments. The asterisk indicates significant difference (P < 0.01) between serum-present (Serum) and serum-deprivation (Serum-free) conditions. control, was observed in cells transfected with the − 285 bp fragment, thus suggesting the presence of minimal regulatory elements within − 285 bp. Luciferase activity in all further lower deletion fragments up to − 2304 bp remained steady at ≈ 2-3-fold.
Since T-cad protein can be up-regulated in HUVEC by culture under conditions of serum-deprivation [10] , we next assessed whether serum deprivation affects the above-described pattern of reporter activity in HMEC-1 cells. For these experiments, luciferase activity in HMEC-1 cells transfected with each of the seven fragments was determined following a 3 h period of serum deprivation. Compared with serum-present conditions, reporter activity for − 99 bp was unchanged, there was a small increase (from 2-to 3-fold) for − 173 bp, and a significant elevation (from 4-to 7-fold, P < 0.01) of reporter activity was observed for − 285 bp ( Figure 1B) . For all further lower deletion constructs (− 373, − 1170, − 1584 and − 2304 bp) there was no upregulation of reporter activity under serum-free conditions.
Promoter structure of T-cad
The sequence of the T-cad minimal promoter region detected by reporter-gene analysis is presented in Figure 2 . Previous studies had demonstrated that T-cad promoter is TATA-less and a GCbox-like sequence is located at − 266 bp [18, 28] . Additionally, three possible transcription start sites at different locations, − 73, − 120 and − 473 bp, in malignant cells have been identified [18, 28] . Database-predicted consensus sequences of regulatory elements are shown in Figure 2 .
Transcription-factor(s)-binding element is present on − 156 to − 203 bp
To search for physical interactions between regulatory elements and transcription factors, we performed gel-shift assays with nuclear extracts prepared from subconfluent proliferating HMEC-1 cells and oligos designed from the T-cad promoter. Since reporter activity was observed within − 173 bp and elevated in − 285 bp, we designed seven different oligos starting from − 1 to − 284 bp; oligos were of 50-60 bp length with minimal overlap in order to maintain integrity of putative regulatory elements. The first series of gel-shift assays aimed to detect interactions between the different oligos and the nuclear extract. Apart from a number of complexes (presumably non-specific) common to all oligos, we detected a nucleoprotein complex unique to the − 156 to − 203 bp oligo ( Figure 3A) , which falls within the minimal promoter region detected by reporter-gene analysis.
To validate the specificity of this nucleoprotein complex, a competition assay was performed with different concentrations of unlabelled − 156 to − 203 bp oligo. We found a concentrationdependent displacement only of the complex unique to − 156 to − 203 bp ( Figure 3B Figure 3C ). Displacement was observed only with its own unlabelled and not with the non-specific unlabelled oligo, further validating specificity of the identified nucleoprotein complex unique to − 156 to − 203 bp.
The − 285 bp region is modulated by oxidative stress
Serum-deprivation-induced increase of T-cad protein in HUVECs is due to oxidative stress [10] . Having demonstrated a serumdeprivation-induced elevation of reporter activity in HMEC-1 transfected with a − 285 bp construct (Figure 1 ), we next investigated whether − 156 to − 203 bp oligo might contain a redox-sensitive regulatory element.
We performed EMSA, RT-PCR and immunoblot analysis after culture of HMEC-1 cells for up to 4 h under conditions of serum deprivation. Gel-shift analysis using the − 156 to − 203 bp oligo revealed an increase in formation of the putative specific nucleoprotein complex within 2 h (Figure 4A ), suggesting that the − 156 to − 203 bp oligo contains relevant binding element(s). T-cad mRNA increased steadily from ≈ 1.5-fold at 2 h to ≈ 4-fold at 4 h ( Figure 4B ). T-cad protein expression increased within 2 h, achieved maximum levels at ≈ 4 h and thereafter declined ( Figure 4B) , similarly to what we have previously reported using HUVECs [10] .
To validate the oxidative-stress-modulated minimal promoter region of T-cad, we examined the influence of serum deprivation and H 2 O 2 as an external source of ROS (reactive oxygen species) on the reporter activity of − 285 bp. Specific ROSdependence of the effects on reporter activity was controlled by inclusion of NAC, a well-characterized thiol-reducing agent that augments the intracellular glutathione pool and counteracts the actions of ROS. Both serum deprivation and H 2 O 2 treatment of HMEC-1 cells transfected with the − 285 bp construct increased reporter activity 2-fold above that under control serum-containing conditions, and these oxidative-stress inductions of reporter activity were abrogated in the presence of NAC ( Figure 5A ). These results suggest that regulatory element(s) located in − 285 bp might be responsible for redox-sensitive modulation of T-cad. RT-PCR analysis ( Figure 5B ) and Western-blot analysis ( Figure 5C ) of parental HMEC-1 cells subjected to serum deprivation or treated with H 2 O 2 showed an NAC-sensitive The promoter region of the T-cad gene was analysed using various databases (see the Materials and methods section). The asterisk ( * ) denotes previously reported transcription start sites [18, 28] . The arge arrowhead ( ) denotes the start codon. In silico-predicted regulatory elements are indicated in bold font, oriented with arrows and labelled below the sequence. A GC-box-like sequence is located at − 266. Ets-transcription-factor-binding elements (GGAA/T) were predicted at − 67, − 119, − 198, − 202 and − 277 bp. C/EBP-binding elements (CCAAT) were predicted at − 154 and − 175 bp. An AHR element (GCGTG) was predicted at − 45 bp. The − 156 to − 203 bp stretch is shaded; previously reported [28] putative binding sites for ER (GGTCA) and GR (CAGC) within this stretch are indicated by braces and labelled above the sequence. (A) Gel-shift assays were performed with radiolabelled oligos designed from the T-cad promoter from − 1 to − 284 bp and nuclear extracts of proliferating subconfluent HMEC-1 cells. Samples were resolved on 4 % (w/v) polyacrylamide gels, and nucleoprotein complexes were detected by phosphorimaging. A representative image from three separate experiments is presented. Apart from complexes common to all oligos and presumed non-specific (n.s.), a complex unique to the − 156 to − 203 bp oligo was observed (indicated by the arrow). Differences in intensity of assumed non-specific complexes are due to non-uniform labelling. A competition assay was performed using radiolabelled − 156 to − 203 bp oligo with various amounts (denoted by [x]) of non-radiolabelled ('cold') − 156 to − 203 bp oligo (B) or with either non-radiolabelled − 156 to − 203 bp oligo or non-specific − 34 to − 83 bp oligo, each at 100 × [x] (C). The double-headed arrow indicates the specific nucleoprotein complex. increase in T-cad transcripts and T-cad protein respectively, confirming redox-sensitive modulation of T-cad expression ( Figure 5B ). Analysis of dose-dependent effects of H 2 O 2 on the expression of T-cad transcript and protein expression and viability (assessed with SYTOX Green staining) in HMEC-1 cells showed up-regulation of T-cad expression also at lower doses of H 2 O 2 ( 50 μM) (see Supplementary Figure S1 at http://www. BiochemJ.org/bj/416/bj4160271add.htm). Furthermore, and as shown previously for the time-dependent effects of serum deprivation on T-cad expression [10] , up-regulation of T-cad in response to H 2 O 2 was associated with the onset of apoptosis.
T-cad induction under oxidative stress is Trx-dependent
We attempted to identify directly transcription factor(s) within the nucleoprotein complex unique to − 156 to − 203 bp using different approaches. The relevance of in silico predicted regulatory elements within − 156 to − 203 bp (Figure 2 ; shaded region) was investigated by using a supershift assay. Antibodies tested included anti-C/EBPα, anti-C/EBPβ, anti-Ets1/2 and anti-GATA-1, but in no case was either a supershift or squelching of specific nucleoprotein complex detected (results not shown). Several efforts to identify transcription factors in nucleoprotein complexes specific to the − 156 to − 206 bp oligo by excision after EMSA and microsequencing also failed. A third approach was to incubate nuclear extracts from serum-deprived HMEC-1 with biotinylated − 156 to − 203 bp in the absence and presence of non-biotinylated − 156 to − 203 bp as competitor, and perform streptavidin-agarose pull-down followed by microsequencing. Microsequencing of complexes pulled down failed to identify a known transcription factor, but did reveal the presence of a peptide with homology with Trx in the complex pulled down from nuclear extracts incubated with biotinylated − 156 to − 203 bp and without competitor. Trxs are members of a class of small (∼ 12 kDa) redox-active proteins; Trx-1 is normally a cytosolic protein, but certain stimuli, including oxidative stress, induce its translocation to the nucleus, where it can modulate transcriptionfactor activities [34] . Western-blot analysis of the complexes confirmed the presence of Trx-1 in a complex pulled down from the biotinylated − 156 to − 203 bp/nuclear extract incubation mixture; Trx-1 was absent when non-biotinylated − 156 to − 203 bp oligo was included as a competitor during incubations ( Figure 6A ). The presence of Trx-1 in nuclear extracts from serum-deprived HMEC-1 cells was additionally demonstrated by direct immunoprecipitation and subsequent Western-blot analysis; Trx-1 was present in anti-Trx-1 antibody precipitates, but not in non-immune antibody precipitates ( Figure 6B) .
To investigate the functional involvement of Trx-1 in the control of T-cad expression under conditions of oxidative stress, we exploited siRNA to knock down Trx-1 expression in both HMEC-1 cells and HUVECs. In both EC types, transfection with Trx-1-siRNA decreased Trx-1 protein levels by + − 60 % within 48 h, In contrast with CArG [CC(A + T-rich)6GG] boxes as musclespecific regulatory elements [35] , EC-specific regulatory elements have not been reported. Spatial and temporal differences in endothelial gene expression have been proposed to account for endothelial heterogeneity and vascular diversity [36, 37] . Similarities exist between promoter of T-cad and those of other cadherins and endothelial-specific genes. For example, the T-cad promoter is TATA-less [18, 28] , as are E-cadherin [38] , P-cad [39] and endothelial markers such as eNOS (endothelial nitric oxide synthase) [40] and VEGF (vascular endothelial growth factor) [41] . Transcription start sites at three different positions, namely at − 73, − 120 and − 473 bp, have been located in osteosarcoma cells [28] and in lung-cancer cell lines [18] . We observed minimal promoter activity within − 285 bp, but not within − 99 bp, indicating that the − 120 bp transcription start site might be functional in ECs. A previous study putatively correlated location of an AHR element at − 45 bp with Ahrligand-dependent repression of T-cad in rat smooth-muscle cells [29] . Since the − 99 bp construct did not exhibit any reporter activity in ECs, it is possible that differences in regulation of T-cad within different constituent cells of the vasculature exist. Support for this assumption derives from observations that vasoactive substances, such as angiotensin II and thrombin, induce T-cad expression in human vascular smooth-muscle cells but not in ECs (M. B. Joshi and T. J. Resink, unpublished work). In the present study, ECs transfected with − 285 bp exhibited a 4-fold increase in minimal reporter activity, whereas a 9-fold increase in reporter activity has been demonstrated in osteosarcoma cells transfected with − 434 bp [28] . Additionally the minimal reporter activity observed within − 285 bp in ECs remained steady with all further deletion fragments tested. An abundance of transcription factor(s), different regulatory proteins or malignancy might explain the higher reporter activity in osteosarcoma cells. Our findings that the antioxidant NAC abrogated oxidative-stress-induced reporter activity in ECs transfected with − 285 bp, and that specific nucleoprotein complex formation (using − 156 to − 203 bp oligo) was greater in extracts from oxidatively stressed ECs, suggest the presence of a redox-modulated regulatory element present within − 285 bp/−156 to − 203 bp in ECs. Under conditions of oxidative stress, induction of reporter activity was observed only for the − 285 bp fragment, but not for further deletion fragments, suggesting a possible presence of negative regulatory elements between − 285 bp to − 373 bp that might be functional under conditions of oxidative stress. The kinetics of nucleoprotein complex formation, T-cad transcription and protein synthesis under oxidative stress depict an effect on mRNA stability, since mRNA levels stayed up-regulated at 4 h, whereas nucleoprotein complex formation and T-cad protein achieved maximum levels between 2 and 3 h and thereafter decreased. Specific nucleoprotein complex formation was observed with the − 156 to − 206 bp oligo, where two copies of GGAA (Etsbinding element), one GATA and two copies of CCAAT (C/EBPbinding element) are located. We were unable to identify a relevant transcription factor either by gel-shift assays using antibodies against Ets1/2, GATA or C/EBP, or by excision and microsequencing of the nucleoprotein complex after EMSA. However, microsequencing of nucleoprotein complex after use of biotinylated − 156 to − 203 bp oligo and streptavidin-agarose pull-down indicated the putative presence of Trx. Western-blot analysis confirmed the presence of a 12 kDa Trx-1 protein within the nucleoprotein complex unique to the − 156 to − 203 bp oligo. The presence of Trx-1 protein in nuclear extracts from serum-deprived HMEC-1 cells was further demonstrated by direct immunoprecipitation with anti-Trx-1 antibodies. These data are in accordance with those obtained in a recent study demonstrating nuclear import of Trx-1 in ECs and cardiomyocytes subjected to oxidative stress [42] .
Trxs compose a class of small multifunctional 12 kDa redoxactive proteins that maintain the reductive intracellular potential. Trx participates in redox reactions by oxidation of its activesite thiol groups and is then reduced by NADPH in a reaction catalysed by the flavoenzyme Trx reductase. Apart from its oxidoreductase functions, Trx controls the activity of a variety of target proteins containing regulatory cysteine residues via reversible thiol-disulfide exchange reactions [34, 43, 44] . Another regulatory mechanism independent of thiol redox activity depends upon the ability of Trx to interact with other proteins to form stable functional protein complexes [45] . These pleiotropic functions of Trx affect diverse cellular processes, including gene expression, signal transduction, proliferation and apoptosis [34, [43] [44] [45] .
Cells are equipped with two Trx species: Trx-1 is primarily present in the cytosol, whereas Trx-2 is located in mitochondria. Several stimuli, including oxidative stress, induce Trx-1 to translocate from the cytoplasm to the nucleus, where it regulates the DNA-binding activity of redox-sensitive transcription factors containing critical cysteine residues in their DNA-binding domains, including NF-κB (nuclear factor-κB), GR, ER, HIF-1α (hypoxia-inducible factor 1α), AP-1 (activator protein 1) and p53 [34, [43] [44] [45] . Trx-1 affects the activity of its target transcription factors by either direct dithiol-disulfide exchange interactions (e.g. NF-κB, GR and ER) and/or indirectly (e.g. NF-κB, AP-1 and p53) via binding to another nuclear redox protein redox factor 1 [34, [43] [44] [45] . Trx may also interact with transcription factors by mechanisms that do not directly depend on dithiol-disulfide exchange: transcription regulators NusG (N-utilization substance G protein) and RcsB (regulator of capsule synthesis B component), which do not contain regulatory cysteine residues, were found in Trx complexes isolated from Escherichia coli, and these interactions were stable in the presence of reducing agents [45] .
We did not identify a target transcription factor with which Trx-1 might interact to induce T-cad transcript expression in ECs. We also do not know which regulatory element within − 156 to − 203 bp of the T-cad gene might be involved; this region does not contain the antioxidant-responsive element that can bind Trx-regulated transcription factors. However, we demonstrated functional relevance for Trx-1 in regulating T-cad expression. siRNA-mediated knockdown of Trx-1 protein in either HMEC-1 cells or HUVECs resulted in an abrogation of serum-deprivation-induced and H 2 O 2 -induced T-cad mRNA and protein expression. These data show that Trx-1 is necessary for T-cad transcription activation in ECs under conditions of oxidative stress. The mechanism whereby Trx-1 might affect T-cad transcription is unknown. Antioxidant functions of Trx-1 are unlikely to be involved, since Trx-1 knockdown abrogated, rather than enhanced, oxidative-stress-induced T-cad transcript expression. Possibly Trx-1 acts more directly [e.g. as an auxiliary transcription (co)factor] in the process of T-cad transcription regulation during oxidative stress.
Trx-1 is a recognized inhibitor of oxidative-stress-induced apoptosis in different cell types, including ECs [42] , although the mechanisms for the anti-apoptotic effects of Trx-1 are very poorly understood. Binding of cytosolic Trx-1 to ASK1 (apoptosis signal-regulating kinase 1) renders it inactive and prevents ASK1-induced apoptosis ( [34, 44] ). Glutathione transferase P1 has been identified as a downstream target for Trx-1-dependent antiapoptosis effects during oxidative stress; nuclear import of Trx-1 and activation of the glutathione transferase P1 gene was shown to be essential for apoptosis inhibition [42] . Up-regulation of Tcad protects EC from oxidative-stress-induced apoptosis [10] . We suggest that Trx-1-dependent activation of T-cad gene expression during oxidative stress could be a novel mechanism for the antiapoptotic effects of Trx-1.
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